InsiderTrades

Form 4 for OGN Organon & Co.

Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001209191-23-027170 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-03 2023-05-01 OGN Ali Kevin CEO, Dir F - Tax $24.63 -1,491 40.7K -4% -$36.7K
D 2023-05-03 2023-05-01 OGN Ali Kevin CEO, Dir M - OptEx — +2,711 42.2K +7% —
D 2023-05-03 2023-05-01 OGN Ali Kevin CEO, Dir M - OptEx $0.00 -2,711 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-01 F D 1,491 $24.63 40,715 D — —
2 Common Common Stock 2023-05-01 M A 2,711 — 42,206 D — — (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested.
3 Derivative Restricted Stock Units 2023-05-01 M D 2,711 $0.00 0 D — · 2023-05-01 to 2023-05-01 2,711 Common Stock (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested.